UCT spin-off receives millions in European funding UCT News
Cape Bio Pharms, a biotech company with roots in the University of Cape Town’s (UCT) Biopharming Research Unit (BRU), has received a multimillion-rand capital injection to fast-track the production of affordable plant-based rapid diagnostic COVID-19 test kits.
You may also like
Prof Rybicki named UCT’s most prolific inventor
Prof Edward Rybicki has been recognised as the University of Cape Town’s most prolific inventor
Watch Video